Business Description
LBX Pharmacy Chain JSC
ISIN : CNE1000023Q8
Share Class Description:
SHSE:603883: Class ACompare
Compare
Traded in other countries / regions
603883.China IPO Date
2015-04-23Description
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.34 | |||||
| Equity-to-Asset | 0.31 | |||||
| Debt-to-Equity | 0.86 | |||||
| Debt-to-EBITDA | 3.57 | |||||
| Interest Coverage | 7.18 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.19 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.3 | |||||
| 3-Year EBITDA Growth Rate | 37.3 | |||||
| 3-Year EPS without NRI Growth Rate | 11.9 | |||||
| 3-Year FCF Growth Rate | 44.4 | |||||
| 3-Year Book Growth Rate | 18.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.01 | |||||
| 9-Day RSI | 68.17 | |||||
| 14-Day RSI | 63.67 | |||||
| 6-1 Month Momentum % | 28.4 | |||||
| 12-1 Month Momentum % | -13.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.85 | |||||
| Quick Ratio | 0.46 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 92.78 | |||||
| Days Sales Outstanding | 30.68 | |||||
| Days Payable | 156.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.57 | |||||
| Dividend Payout Ratio | 0.34 | |||||
| 3-Year Dividend Growth Rate | 22.1 | |||||
| Forward Dividend Yield % | 1.57 | |||||
| 5-Year Yield-on-Cost % | 2.56 | |||||
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | 3.1 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.77 | |||||
| Operating Margin % | 7.09 | |||||
| Net Margin % | 3.97 | |||||
| FCF Margin % | 6.69 | |||||
| ROE % | 13.5 | |||||
| ROA % | 4.24 | |||||
| ROIC % | 8.61 | |||||
| ROC (Joel Greenblatt) % | 36.11 | |||||
| ROCE % | 14.94 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.79 | |||||
| PE Ratio without NRI | 21.33 | |||||
| Shiller PE Ratio | 29.45 | |||||
| Price-to-Owner-Earnings | 38.69 | |||||
| PEG Ratio | 0.65 | |||||
| PS Ratio | 0.82 | |||||
| PB Ratio | 2.79 | |||||
| Price-to-Tangible-Book | 81.56 | |||||
| Price-to-Free-Cash-Flow | 12.34 | |||||
| Price-to-Operating-Cash-Flow | 10.08 | |||||
| EV-to-EBIT | 13.72 | |||||
| EV-to-EBITDA | 13.72 | |||||
| EV-to-Revenue | 0.98 | |||||
| EV-to-FCF | 14.38 | |||||
| Price-to-Projected-FCF | 0.88 | |||||
| Price-to-DCF (Earnings Based) | 1.12 | |||||
| Price-to-DCF (FCF Based) | 0.4 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.24 | |||||
| Price-to-Graham-Number | 8.79 | |||||
| Earnings Yield (Greenblatt) % | 7.29 | |||||
| FCF Yield % | 8.06 | |||||
| Forward Rate of Return (Yacktman) % | 24.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LBX Pharmacy Chain JSC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 22,440.624 | ||
| EPS (TTM) (Â¥) | 1.53 | ||
| Beta | 1.64 | ||
| Volatility % | 31.76 | ||
| 14-Day RSI | 63.67 | ||
| 14-Day ATR (Â¥) | 0.893798 | ||
| 20-Day SMA (Â¥) | 30.2325 | ||
| 12-1 Month Momentum % | -13.38 | ||
| 52-Week Range (Â¥) | 22.81 - 36.08 | ||
| Shares Outstanding (Mil) | 584.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LBX Pharmacy Chain JSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LBX Pharmacy Chain JSC Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
LBX Pharmacy Chain JSC Frequently Asked Questions
What is LBX Pharmacy Chain JSC(SHSE:603883)'s stock price today?
The current price of SHSE:603883 is ¥31.81. The 52 week high of SHSE:603883 is ¥36.08 and 52 week low is ¥22.81.
When is next earnings date of LBX Pharmacy Chain JSC(SHSE:603883)?
The next earnings date of LBX Pharmacy Chain JSC(SHSE:603883) is .
Does LBX Pharmacy Chain JSC(SHSE:603883) pay dividends? If so, how much?
The Dividend Yield %  of LBX Pharmacy Chain JSC(SHSE:603883) is 1.57% (As of Today), Highest Dividend Payout Ratio of LBX Pharmacy Chain JSC(SHSE:603883) was 0.69. The lowest was 0.22. And the median was 0.28. The  Forward Dividend Yield % of LBX Pharmacy Chain JSC(SHSE:603883) is 1.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers